Login
$BCTX
$3.30 -$0.09 (2.65%) Live

$BCTX SEC Filings

Filed On Filing
28 Oct 2026 10-K
26 Jun 2026 8-K: Regulation FD Disclosure

The accompanying Unaudited Condensed Interim Consolidated Financial Statements of BriaPro Therapeutics Corp. for the three and nine month periods ended April 30, 2026 and 2025 have been prepared by management in accordance with Internati...

09 Jun 2026 10-Q
03 Jun 2026 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more

This Placement Agency Agreement (the “Agreement”) sets forth the terms upon which ThinkEquity LLC (“ThinkEquity” or the “Placement Agent”) shall be engaged by BriaCell Therapeutics Corp., a corporation formed under the laws of the Provin...

02 Jun 2026 424B5
31 Mar 2026 8-K: Regulation FD Disclosure

The following Management’s Discussion and Analysis (“MD&A”) for BRIAPRO THERAPEUTICS CORP. (“BriaPro” or the “Company”) is prepared as of March 31, 2026 and relates to the unaudited condensed interim financial condition and results of op...

10 Mar 2026 10-Q
09 Mar 2026 8-K: Submission of Matters to a Vote of Security Holders

On March 5, 2026, BriaCell Therapeutics Corp. (the “Company”) held its Annual General and Special Meeting of Shareholders (the “Meeting”). As of January 26, 2026, the date of record for determining the shareholders entitled to vote on th...

26 Feb 2026 25-NSE
20 Feb 2026 8-K: Other Events

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, BCTXL) (TSX: BCT) (“BriaCell”), a clinical-stage biotechnology company that develops novel immunothe...

12 Feb 2026 DEF 14A
23 Jan 2026 SCHEDULE 13G
15 Jan 2026 8-K: Entry into a Material Definitive Agreement; Other Events

This Placement Agency Agreement (the “Agreement”) sets forth the terms upon which ThinkEquity LLC (“ThinkEquity” or the “Placement Agent”) shall be engaged by BriaCell Therapeutics Corp., a corporation formed under the laws of the Provin...

14 Jan 2026 424B4
13 Jan 2026 EFFECT
13 Jan 2026 S-1MEF
13 Jan 2026 CERT
13 Jan 2026 8-A12B
08 Jan 2026 CORRESP
08 Jan 2026 CORRESP

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support